However, the NLRP3 inflammasome is essential for antitumor adaptive immunity in bladder cancer (BC) and renal cell carcinoma (RCC), and its pyroptosis pathway has demonstrated potent antitumor effects. This evidence concerns the gene NLRP3 and breast cancer.